Mercer Global Advisors
INTS icon

Mercer Global Advisors’s Intensity Therapeutics INTS Stock Holding History

Mercer Global Advisors’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197 Buy
+48
New +$226 ﹤0.01% 5919

Other funds holding INTS

KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Mercer Global Advisors's INTS Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Intensity Therapeutics (INTS) in Q2 2026: 48 shares worth $197. The stake represents ﹤0.01% of the portfolio and ranks #5919 among its holdings.

14 funds tracked by Wall St. Rank hold INTS as of Q2 2026.

  • Mercer Global Advisors held 48 shares of Intensity Therapeutics worth $197 as of Q2 2026.
  • Intensity Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Intensity Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5919 holding.
  • 14 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.